2393 related articles for article (PubMed ID: 17460438)
1. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
4. [New aspects in ANCA-associated vasculitides].
Lamprecht P
Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
7. [ANCA-associated vasculitis].
Sinico RA; Sabadini E; Boeri R; Radice A
G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
9. [Systemic ANCA-associated vasculitis--diagnosis and therapy].
Eisenberger U; Hess C
Ther Umsch; 2008 May; 65(5):295-301. PubMed ID: 18622935
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of ANCA-positive systemic vasculitis with intravenous immunoglobins].
Mouthon L
Rev Med Interne; 1999; 20 Suppl 4():431s-435s. PubMed ID: 10522318
[TBL] [Abstract][Full Text] [Related]
11. ANCA-Associated Vasculitis: Core Curriculum 2020.
Geetha D; Jefferson JA
Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
[TBL] [Abstract][Full Text] [Related]
12. ANCA Glomerulonephritis and Vasculitis.
Jennette JC; Nachman PH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1680-1691. PubMed ID: 28842398
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe.
Ito-Ihara T; Muso E; Kobayashi S; Uno K; Tamura N; Yamanishi Y; Fukatsu A; Watts RA; Scott DG; Jayne DR; Suzuki K; Hashimoto H
Clin Exp Rheumatol; 2008; 26(6):1027-33. PubMed ID: 19210866
[TBL] [Abstract][Full Text] [Related]
15. [ANCA(antineutrophil cytoplasmic antibodies)-associated vasculitis in a man with extreme fatigue, fever and progressive renal dysfunction].
Bakashvili N; Swaak AJ; Tervaert JW; Dees A
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):1009-14. PubMed ID: 18549177
[TBL] [Abstract][Full Text] [Related]
16. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
Holle JU
Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
[No Abstract] [Full Text] [Related]
17. Diagnostics and therapy of antineutrophil cytoplasmic antibody (ANCA) associated vasculitides.
Reinhold-Keller E
Curr Pharm Des; 2012; 18(29):4537-41. PubMed ID: 22612757
[TBL] [Abstract][Full Text] [Related]
18. ANCA associated vasculitis (AAV): a review for internists.
Yaseen K; Mandell BF
Postgrad Med; 2023 Jan; 135(sup1):3-13. PubMed ID: 35831990
[TBL] [Abstract][Full Text] [Related]
19. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
[TBL] [Abstract][Full Text] [Related]
20. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
